Nackers Fabienne, Tonglet René, Slachmuylder Véronique, Johnson Roch C, Robert Annie, Zinsou Claude, Glynn Judith R, Portaels Françoise, Gala Jean-Luc
Epidemiology Unit, Université Catholique de Louvain, Brussels, Belgium.
Trop Med Int Health. 2007 Apr;12(4):511-8. doi: 10.1111/j.1365-3156.2006.01808.x.
Risk factors for Buruli ulcer (BU) are poorly understood. We conducted a case-control study in southern Benin to investigate the association between haemoglobin variants S or C and BU, and particularly the association between haemoglobinopathies HbSS/SC and BU osteomyelitis. We compared the haemoglobin genotype of 179 patients with BU and 44 with BU osteomyelitis to that of 242 community controls. We found no evidence of an increased risk of BU according to the presence of haemoglobin variants S and/or C [odds ratio adjusted for sex, age, region of residence and ethnicity: 1.24 (95% CI: 0.80-1.93), P = 0.34]. Haemoglobin variants S and C are unlikely to play a role in the BU burden. However, haemoglobinopathies HbSS/SC were more frequent among BU osteomyelitis patients than among controls (6.8% vs. 1.0%, Fisher's exact P-value = 0.045), which may suggest that those disorders facilitate growth of Mycobacterium ulcerans in the bone matrix.
对布氏杆菌溃疡(BU)的危险因素了解甚少。我们在贝宁南部开展了一项病例对照研究,以调查血红蛋白变异体S或C与BU之间的关联,特别是血红蛋白病HbSS/SC与BU骨髓炎之间的关联。我们将179例BU患者和44例BU骨髓炎患者的血红蛋白基因型与242名社区对照者的进行了比较。我们没有发现证据表明存在血红蛋白变异体S和/或C会增加患BU的风险[根据性别、年龄、居住地区和种族调整后的优势比:1.24(95%置信区间:0.80-1.93),P = 0.34]。血红蛋白变异体S和C不太可能在BU负担中起作用。然而,血红蛋白病HbSS/SC在BU骨髓炎患者中比在对照者中更常见(6.8%对1.0%,Fisher精确P值 = 0.045),这可能表明这些病症促进溃疡分枝杆菌在骨基质中的生长。